Replies to post #34271 on Revive Therapeutics Ltd (RVVTF)

[Bluehorseshoe66]

IMO, the stock is being punished for misqueues by management.

I believe in the science of this drug but the Revive team simply doesn't have enough "hands", experience, persuasion, etc. to make it go faster or better.

I'm long on Bucillamine and will continue to hold my considerably large stack until there is a final outcome.

BTW, your question could be asked about many different investments at this point, it's been a rough ride in 2022!